📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: iCardiac

1.1 - Company Overview

iCardiac Logo

iCardiac

Headquarter: United States
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of cardiac safety biomarkers and ECG-based markers for assessing the cardiac safety profile of drugs in development; offers Dynamic QTbtbsm, a suite of ECG-based cardiac safety markers, used in cardiac clinical trials by pharmaceutical, biotechnology, and medical device companies.

Products and services

🔒

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to iCardiac

Oncodesign Logo

Oncodesign

HQ: France Website
  • Description: Provider of precision medicine-driven oncology preclinical CRO services and biopharmaceutical R&D, developing anticancer therapies and leveraging platforms such as Nanocyclix for selective kinase inhibitors and OncoSNIPER AI for resistant patient stratification. Pipeline includes OPM-101 (RIPK2, IBD), OPM-102 (RIPK2, inflammation-related tumors), and an LRRK2 program (Parkinson’s), plus the IMODI cluster for cancer models and microbiota studies.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Oncodesign company profile →
Base Life Science Logo

Base Life Science

HQ: Denmark Website
  • Description: Provider of information technology consulting and solutions, including the BASE Migration Framework for complex, compliant data migrations; Veeva Development Cloud services for process strategy, implementation, training, and post-implementation support; clinical process optimization, system training and implementation (CDMS, eTMF, CTMS); and CRO onboarding and oversight.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Base Life Science company profile →
Selcia Logo

Selcia

HQ: United States Website
  • Description: Provider of integrated drug discovery services and high quality 14C radiolabelled compounds to pharma, biotechnology companies and academia.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Selcia company profile →
QPS Logo

QPS

HQ: United States Website
  • Description: Provider of GLP/GCP-compliant contract research services spanning discovery, preclinical and clinical drug development, including neuropharmacology, DMPK, toxicology, bioanalysis, translational medicine, and clinical development support.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full QPS company profile →
Canopy Biosciences Logo

Canopy Biosciences

HQ: United States Website
  • Description: Provider of biotechnological products and services for gene editing and personalized medicine, including TUNR technology targeting translation elongation by inserting polyA tracks to decrease mRNA levels. Offerings include CellScape for spatial biology and multi-omic imaging with biomarker quantification; ChipCytometry for quantitative protein biomarker measurement; NanoString nCounter gene expression analysis; single-cell transcriptome profiling; and clinical deep phenotyping.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Canopy Biosciences company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for iCardiac

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to iCardiac

2.2 - Growth funds investing in similar companies to iCardiac

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for iCardiac

4.2 - Public trading comparable groups for iCardiac

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to iCardiac

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About iCardiac

What does iCardiac do?

iCardiac is a provider of cardiac safety biomarkers and ECG-based markers for assessing the cardiac safety profile of drugs in development; offers Dynamic QTbtbsm, a suite of ECG-based cardiac safety markers, used in cardiac clinical trials by pharmaceutical, biotechnology, and medical device companies.

Who are iCardiac's competitors?

iCardiac's competitors and similar companies include Oncodesign, Base Life Science, Selcia, QPS, and Canopy Biosciences.

Where is iCardiac headquartered?

iCardiac is headquartered in United States.

How many employees does iCardiac have?

iCardiac has 1,000 employees 🔒.

When was iCardiac founded?

iCardiac was founded in 2010 🔒.

What sector and industry vertical is iCardiac in?

iCardiac is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for iCardiac

Who are the top strategic acquirers in iCardiac's sector and industry

Top strategic M&A buyers and acquirers in iCardiac's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for iCardiac?

Top strategic M&A buyers groups and sectors for iCardiac include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in iCardiac's sector and industry vertical

Which are the top PE firms investing in iCardiac's sector and industry vertical?

Top PE firms investing in iCardiac's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in iCardiac's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in iCardiac's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in iCardiac's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to iCardiac include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in iCardiac's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for iCardiac?

The key public trading comparables and valuation benchmarks for iCardiac include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for iCardiac for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for iCardiac with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in iCardiac's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for iCardiac with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in iCardiac's' sector and industry vertical?

Access recent funding rounds and capital raises in iCardiac's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for iCardiac